시장보고서
상품코드
1663438

세계의 AI 기반 디지털 병리학 시장 : 신경망별, 컴포넌트별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

AI-based Digital Pathology Market, By Neural Network, By Component, By Application, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 381 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

AI 기반 디지털 병리학 시장 규모는 2024년 8,560만 달러로 평가되었고, 2025년부터 2032년까지 15.80%의 연평균 복합 성장률(CAGR)로 확대

AI 기반 디지털 병리학 시장 - 시장 역학

맞춤형 의료에 대한 수요 증가

AI 기반 디지털 병리학 시장은 개별화된 투약에 대한 수요가 증가함에 따라 향후 확대될 것으로 예측됩니다. 각 환자의 요구, 선호 및 특징에 맞게 의료 및 치료를 사용자 정의하는 것은 맞춤형 의료로 알려져 있습니다. 개인화된 의료는 각 환자 고유의 유전자 프로파일, 라이프스타일의 선택, 질병의 특성에 맞게 치료법을 맞춤화함으로써 효능을 향상시키고 부작용을 줄이기 위해 필요성이 증가하고 있습니다. 유전자 데이터와 의료 영상을 보다 정확하고 효율적으로 분석할 수 있게 함으로써, AI를 활용한 디지털 병리학는 보다 정확한 진단, 질환 하위 유형의 식별, 각 환자 특유의 생물학적 프로파일에 맞춘 치료 요법의 커스터마이즈를 용이하게 해, 맞춤형 의료를 지원합니다. 예를 들어, 2023년 2월 미국에 본사를 둔 전문가 회원 조직인 Personalized Medicine Coalition이 발표한 보고서에 따르면 2022년에는 12개의 새로운 맞춤형 치료제가 승인되었으며, 이는 전신 치료제의 약 34%에 해당하며 그 이전에 비해 현저한 증가를 보여줍니다. 이와 같이 AI 기반 디지털 병리학 시장은 맞춤형 치료에 대한 수요가 증가함에 따라 확대되고 있습니다.

AI 기반 디지털 병리학 시장 - 주요 인사이트력

우리의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2025-2032년)에 약 15.80%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

신경망의 세분화에 기초하여, 컨벌루션 신경망(CNN)은 2024년 최대 시장 점유율을 나타냈습니다.

용도별로, 의약품은 2024년의 주요 부문이었습니다.

최종 용도 세분화를 바탕으로 2024년에는 병원과 레퍼런스 실험실이 주요 부문이었습니다.

지역별로는 아시아태평양이 2024년 매출을 이끌었습니다.

AI 기반 디지털 병리학 시장 - 세분화 분석 :

세계의 AI 기반 디지털 병리학 시장은 신경망, 컴포넌트, 용도, 최종 용도, 지역에 따라 세분화됩니다.

구성 요소 기반에서 시장은 스캐너와 소프트웨어로 구분됩니다. 2024년에는 시장이 소프트웨어 카테고리에 의해 지배되었습니다. 이는 디지털 병리학에서 인공지능 소프트웨어의 사용이 증가하고 있기 때문에 병리학자의 시간, 정밀도, 결과의 속도가 저하되어, 의사가 환자의 건강 상태를 평가해, 회복약을 신속하게 스케줄할 수 있게 된 것이 그 요인입니다. 또한, AI는 환자의 건강 데이터를 저장하고 결과를 검색하는 데 효과적으로 사용될 수 있으며, 조사 기간 동안 AI 기반 디지털 병리학 소프트웨어에 대한 수요가 증가합니다.

최종 용도에 따라 시장은 병원 및 기준 검사실, 제약 및 바이오테크놀러지 기업, 학술기관 및 연구기관으로 나눌 수 있습니다. 2024년에는 병원 및 기준 검사실 카테고리가 압도적인 시장 점유율을 차지하고 있습니다. 병원과 기준 검사실은 아마 날마다 증가하는 병리학 관련 사례를 다루게 될 것입니다. 병리검사의 업무 부담이 늘어남에 따라 신뢰성 높은 결과를 내는 능력과 시간 절약 능력에 의해 AI의 이용이 필요하게 됩니다. 또한 병원은 인공지능 덕분에 더 많은 사례를 관리하는 데 필요한 병리 의사의 수를 줄일 수 있습니다. 이를 통해 세계 AI 기반 디지털 병리학 시장이 향후 수년간 성장할 수 있는 새로운 길을 더욱 열어줄 것입니다.

AI 기반 디지털 병리학 시장 - 지리적 통찰

2024년 아시아태평양은 AI 기반 디지털 병리학 진단 세계 시장에서 지배적인 지위를 차지했습니다. AI 기반 디지털 병리학 시장은 중국과 인도와 같은 신흥 국가에서 의료 분야에서 AI 적용을 확대함으로써 확대되고 있습니다. NASSCOM에 따르면 2025년까지 인도의 헬스케어 AI 시장은 CAGR 40%로 확대될 것으로 예측되고 있습니다. 이는 의료 분야에서 AI의 사용이 확대되고 있음을 나타내며 반복 작업을 신속하게 완료하고 병리학의 시간을 절약할 수 있으므로 병리학에서 응용이 촉진될 수 있습니다. 인공지능은 병리의사 관련 업무의 일부를 해낼 수 있기 때문에 이 분야에서 하급 병리의의 존재가 헬스케어 개업의의 이용을 뒷받침해, 조사 기간중 수요를 높이고 있습니다.

그러나 예측기간을 통해 북미지역은 원격의료 이용이 확대되고 있기 때문에 CAGR이 가장 빠를 것으로 예측되고 있습니다. COVID-19는 엄격한 감금 요건으로 인해 대면 세션 대신 원격 의료 사용을 장려했습니다. 미국 보건사회 복지성에 따르면 미국의 메디케어 수급자는 유행 이후 원격 의료를 자주 이용하고 있습니다. 미국에서는 2019년 11억 건에서 2020년 9억 8,900만 건의 대면 진료가 있었습니다. 원격진료 예약 건수는 2019년 840만 건에서 2020년 5,270만 건 가까이 증가했습니다. 거래 비용의 감소로 인해 증가가 예상되는 이러한 동향의 진전에 따라 의사가 원격 진료를 지원하는 AI 기반 기술이 필요합니다.

AI 기반 디지털 병리학 시장 - 경쟁 구도:

DoMore Diagnostics AS, Aiforia Technologies, Aiosyn, Deep Bio, F. Hoffmann-La Roche 등 AI 기반 디지털 병리학 시장의 주요 기업은 환자의 결과를 개선하고, 프로세스를 가속화하고, 진단 정확도를 높이기 위해 고급 암 검출 장비와 같은 최첨단 제품을 개발하는 데 주력하고 있습니다. AI를 갖춘 고급 암 검출 도구는 딥러닝 모델과 머신러닝 알고리즘을 사용하여 병리학 슬라이드와 의료 이미지를 평가하여 종양 식별 및 분류 정확도를 향상시킵니다. 예를 들어, 2022년 2월 Crosscope Inc.와 MindPeak GmbH는 MindPeak의 이미지 분석 도구를 Crosscope의 Digital Pathology 플랫폼에 통합하여 제휴했습니다. 크로스코프의 AI 능력은 이 제휴에 의해 향상되어 완전한 디지털 병리학 솔루션을 제공할 수 있게 되었습니다. 최첨단 AI 도구의 원활한 통합을 통해 이 협업은 병리 조직학 워크플로우를 간소화하고 병리 의사가 실험실 생산성을 향상시키고 ER, PR, Ki-67 IHC 분석에서 빠르고 중요한 진단을 제공할 수 있도록 돕고자 합니다. 통합의 결과, 환자의 치료 성적이 향상될 것으로 기대됩니다.

최근 개발 동향

2024년 1월: Roche는 미국 캘리포니아주 버클리에 본사를 둔 비상장 기업인 Carmot Therapeutics, Inc.("Carmot")를 인수하는 합병 계약을 최종 결정했다고 발표했습니다. Carmot의 R&D 포트폴리오에는 당뇨병의 유무에 관계없이 비만증 치료제로 동급 최고의 잠재력을 가진 전임상시험과 임상 단계의 경구 및 피하 인크레틴이 포함됩니다.

2023년 10월: 클라우드 서비스 제공업체인 Amazon Web Services, Inc.의 협력을 통해 F. Hoffmann-La Roche Ltd.와 Ibex Medical Analytics Ltd.는 AI를 활용한 암 검출 솔루션을 제공하기 위해 제휴했습니다. 이 제휴는 Navify Digital Pathology 소프트웨어 플랫폼을 통해 병리 검사실에 아이벡스의 AI 구동형 의사결정 지원 기능에 대한 액세스를 제공합니다. 임상의는 이 통합을 통해 전립선암이나 유방암의 진단 지원을 받을 수 있습니다.

2023년 9월: 유럽, 캐나다, 아시아태평양 시장에서 Hologic, Inc.와 Bayer AG는 더 나은 유방암 발견을 위한 조영 유방촬영(CEM) 솔루션을 제공하기 위해 제휴했습니다. Bayer와 Hologic의 기술을 결합하여 유방 조영술 검사 시 조영제 적용을 보다 쉽게 할 수 있을 것으로 기대합니다. 이 제휴는 방사선 기술자에게 완벽한 제품 번들, 실용적인 지도, 부드러운 CEM 워크플로우 통합을 제공하는 데 중점을 둡니다.

2023년 6월: 미국에 본사를 둔 디지털 병리학 및 컴퓨팅 병리 솔루션공급업체인 Proscia Inc.는 MindPeak GmbH와 제휴했습니다. 이 제휴는 AI를 활용한 워크플로우를 긴밀하게 연계시킴으로써 병리의가 보다 효과적이고 지식이 풍부하고 재현성 있는 임상결론에 도달할 수 있도록 지원하는 것을 목표로 합니다. 그 목적은 암 환자가 더 나은 진단을받을 수 있도록하는 것입니다.

목차

제1장 AI 기반 디지털 병리학 시장 개요

  • 조사 범위
  • 시장 추정년

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 AI 기반 디지털 병리학의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 AI 기반 디지털 병리학 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 AI 기반 디지털 병리학 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 AI 기반 디지털 병리학 시장 상황

  • AI 기반 디지털 병리학 시장 점유율 분석, 2024년
  • 분석 데이터 : 주요 제조업체별
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 AI 기반 디지털 병리학 시장 - 신경망별

  • 개요
    • 신경망에 의한 부문 점유율 분석
    • 생성적 적대 네트워크(GANS)
    • 리커런트 신경망(RNN)
    • 컨벌루션 신경망(CNN)
    • 기타

제8장 AI 기반 디지털 병리학 시장 - 컴포넌트별

  • 개요
    • 부문 점유율 분석 : 컴포넌트별
    • 스캐너
    • 소프트웨어

제9장 AI 기반 디지털 병리학 시장 - 용도별

  • 개요
    • 부문 점유율 분석 : 용도별
    • 창약
    • 임상 워크플로우
    • 트레이닝 및 교육
    • 질병의 진단과 예후

제10장 AI 기반 디지털 병리학 시장 - 최종 용도별

  • 개요
    • 부문 점유율 분석 : 최종 용도별
    • 병원·검사 기관
    • 제약·바이오테크놀러지 기업
    • 학술기관 및 연구기관

제11장 AI 기반 디지털 병리학 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 영국
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 한국
    • 일본
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석-AI 기반 디지털 병리학 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • DoMore Diagnostics AS
    • Aiforia Technologies
    • Aiosyn
    • Deep Bio
    • F. Hoffmann-La Roche
    • Akoya Biosciences
    • deepPath
    • Hologic
    • Konfoong Biotech International
    • Koninklijke Philips NV
    • 4D Path
    • Lumea
    • Ibex Medical Analytics
    • Indica Labs
    • Mindpeak
    • 기타

제13장 애널리스트의 전방위 전망

JHS 25.03.14

REPORT HIGHLIGHT

AI-based Digital Pathology Market size was valued at US$ 85.6 Million in 2024, expanding at a CAGR of 15.80% from 2025 to 2032.

AI-based digital pathology is a cutting-edge method of using digital technologies and artificial intelligence to diagnose and analyze illnesses. In order to identify patterns, anomalies, and particular disease signs, pathology slides are digitized into high-resolution images and subsequently sent to AI algorithms for analysis. By automating repetitive procedures, increasing diagnostic precision, and spotting minute details that would be overlooked during manual inspection, these AI systems might help pathologists. The AI-based digital pathology market is growing as a result of the growing emphasis on hospital cost control and efficiency enhancement, the rising need for technologically sophisticated solutions, and the rising number of incorrect diagnoses. Additionally, it is anticipated that government-funded research initiatives that support the creation of cutting-edge digital tools for pathology would support the AI-based digital pathology market growth.

AI-based Digital Pathology Market- Market Dynamics

Growing demand for personalized medication

The market for AI-based digital pathology is anticipated to increase in the future due to the growing demand for personalized medication. Customizing medical care and treatment to each patient's unique needs, preferences, and traits is known as personalized medicine. Personalized medicine is becoming more and more necessary in order to improve efficacy and decrease side effects by customizing therapies to each patient's unique genetic profile, lifestyle choices, and illness features. By making it possible to analyze genetic data and medical images more accurately and efficiently, AI-based digital pathology supports personalized medicine by facilitating more precise diagnosis, improved identification of disease subtypes, and customized treatment regimens that fit each patient's particular biological profile. For instance, a report released in February 2023 by the US-based professional membership organization Personalized Medicine Coalition stated that the approval of 12 new personalized medications in 2022-roughly 34% of all new therapies-represented a notable increase over prior years. Thus, the market for AI-based digital pathology is expanding due to the growing demand for tailored therapy.

AI-based Digital Pathology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.80% over the forecast period (2025-2032)

Based on neural network segmentation, the convolutional neural networks (CNNs) were predicted to show maximum market share in the year 2024

Based on application segmentation, drug discovery was the leading segment in 2024

Based on end use segmentation, hospitals & reference laboratories were the leading segment in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

AI-based Digital Pathology Market- Segmentation Analysis:

The Global AI-based Digital Pathology Market is segmented on the basis of Neural Network, Component, Application, End Use, and Region.

On the basis of component, the market is segregated into Scanners and Software. In 2024, the market was dominated by the software category due to the increasing use of artificial intelligence software in digital pathology, which has been fueled by a decrease in pathologists' time, accuracy, and speed of results, enabling physicians to assess a patient's health and schedule recovery medication rapidly. Additionally, AI may be used effectively to store patient health data and retrieve results, which will increase the demand for AI-based digital pathology software during the study period.

Based on end use, the market is divided into Hospitals & Reference Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. In 2024, the hospitals & reference laboratories category held a dominant market share. Hospitals and reference labs will probably deal with an increasing number of pathology-related cases every day. The increasing burden for pathology jobs will need the use of AI due to its ability to produce reliable results and its time-saving capabilities. Additionally, hospitals can reduce the number of pathologists they require to manage more cases thanks to AI. This will further open up new avenues for the global AI-based digital pathology market to grow in the years to come.

AI-based Digital Pathology Market- Geographical Insights

In 2024, Asia-Pacific held a dominant position in the global market for AI-based Digital Pathology. The market for AI-based digital pathology is expanding due to the expanding application of AI in healthcare sectors in developing nations like China and India. By 2025, the healthcare AI market in India is anticipated to expand at a 40% CAGR, according to NASSCOM. This illustrates the growing usage of AI in the medical field, which could encourage its application in pathology due to its speedy completion of repetitive tasks and capacity to save pathologists time. Because artificial intelligence can do some pathologist-related duties, the presence of lower-level pathologists in the area is pushing healthcare practitioners to use it, increasing demand for it during the research period.

However, throughout the projected period, the North America region is anticipated to see the fastest CAGR because of the growing use of telemedicine. Due to strict lockdown requirements, COVID-19 encouraged the use of telemedicine instead of in-person sessions. Medicare beneficiaries in the US have been using telemedicine more frequently since the epidemic, according to the US Department of Health and Human Services. In the United States, there were 989 million in-person medical visits in 2020, up from 1.1 billion in 2019. By 2020, there were almost 52.7 million telemedicine appointments, up from 8,40,000 in 2019. AI-based technologies that assist physicians in treating patients remotely will be required as this trend, which is anticipated to increase due to decreased transaction costs, develops.

AI-based Digital Pathology Market- Competitive Landscape:

Leading players in the AI-based digital pathology market, such as DoMore Diagnostics AS, Aiforia Technologies, Aiosyn, Deep Bio, F. Hoffmann-La Roche, and others, are concentrating on creating cutting-edge products, such as sophisticated cancer detection instruments to boost patient outcomes, expedite processes, and increase diagnostic precision. AI-powered advanced cancer detection tools use deep learning models and machine learning algorithms to evaluate pathology slides and medical images, improving the precision of tumour identification and classification. For instance, in February 2022, Crosscope Inc. and MindPeak GmbH partnered to include MindPeak's image analysis tools into Crosscope's Digital Pathology platform. Crosscope's AI capabilities are improved by this collaboration, allowing them to offer complete digital pathology solutions. Through the smooth integration of cutting-edge AI tools, the collaboration seeks to streamline Histopathology workflows, assisting pathologists in enhancing lab productivity and providing prompt and significant diagnoses for ER, PR, and Ki-67 IHC analysis. Treatment outcomes for patients are expected to improve as a result of the integration.

Recent Development

January 2024: Roche declared that it had finalized a merger deal to buy Berkeley, California-based Carmot Therapeutics, Inc. ("Carmot"), a privately held US business. Carmot's research and development portfolio includes a range of preclinical studies and clinically staged oral and subcutaneous incretins with best-in-class potential to treat obesity in individuals with and without diabetes.

October 2023: With the help of cloud service provider Amazon Web Services, Inc., F. Hoffmann-La Roche Ltd. and Ibex Medical Analytics Ltd. have partnered to offer AI-powered cancer detection solutions. Through the Navify Digital Pathology software platform, this partnership seeks to provide pathology labs with access to Ibex's AI-driven decision support capabilities. Clinicians can get help diagnosing prostate and breast cancer through this integration.

September 2023: In the European, Canadian, and Asia Pacific markets, Hologic, Inc. and Bayer AG have teamed together to offer contrast-enhanced mammography (CEM) solutions for better breast cancer detection. By combining Bayer and Hologic's technology, the alliance hopes to make it easier to apply contrast media during mammography exams. The collaboration is centred on offering radiologists complete product bundles, practical instruction, and smooth CEM workflow integration.

June 2023: Proscia Inc., a U.S.-based supplier of digital and computational pathology solutions, has partnered with MindPeak GmbH. Through closely coordinated AI-powered workflows, this collaboration seeks to assist pathologists in reaching more effective, knowledgeable, and repeatable clinical conclusions. The objective is to increase cancer patients' access to better diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • DoMore Diagnostics AS
  • Aiforia Technologies
  • Aiosyn
  • Deep Bio
  • F. Hoffmann-La Roche
  • Akoya Biosciences
  • deepPath
  • Hologic
  • Konfoong Biotech International
  • Koninklijke Philips N.V.
  • 4D Path
  • Lumea
  • Ibex Medical Analytics
  • Indica Labs
  • Mindpeak
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY NEURAL NETWORK- MARKET ANALYSIS, 2019 - 2032

  • Generative adversarial networks (GANS)
  • Recurrent neural networks (RNNs)
  • Convolutional neural networks (CNNs)
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Scanners
  • Software

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery
  • Clinical Workflow
  • Training & Education
  • Disease Diagnosis & Prognosis

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Reference Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI-based Digital Pathology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Digital Pathology Market Snippet by Neural Network
    • 2.1.2. AI-based Digital Pathology Market Snippet by Component
    • 2.1.3. AI-based Digital Pathology Market Snippet by Application
    • 2.1.4. AI-based Digital Pathology Market Snippet by End Use
    • 2.1.5. AI-based Digital Pathology Market Snippet by Country
    • 2.1.6. AI-based Digital Pathology Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Digital Pathology Key Market Trends

  • 3.1. AI-based Digital Pathology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Digital Pathology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Digital Pathology Market Opportunities
  • 3.4. AI-based Digital Pathology Market Future Trends

4. AI-based Digital Pathology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Digital Pathology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Digital Pathology Market Landscape

  • 6.1. AI-based Digital Pathology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Digital Pathology Market - By Neural Network

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Neural Network, 2024 & 2032 (%)
    • 7.1.2. Generative adversarial networks (GANS)
    • 7.1.3. Recurrent neural networks (RNNs)
    • 7.1.4. Convolutional neural networks (CNNs)
    • 7.1.5. Others

8. AI-based Digital Pathology Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 8.1.2. Scanners
    • 8.1.3. Software

9. AI-based Digital Pathology Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery
    • 9.1.3. Clinical Workflow
    • 9.1.4. Training & Education
    • 9.1.5. Disease Diagnosis & Prognosis

10. AI-based Digital Pathology Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Reference Laboratories
    • 10.1.3. Pharmaceutical & Biotechnology Companies
    • 10.1.4. Academic & Research Institutes

11. AI-based Digital Pathology Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. AI-based Digital Pathology Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. AI-based Digital Pathology Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. France
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.9.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. Italy
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. Italy Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.10.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Spain
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. United Kingdom
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. United Kingdom Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.12.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. Russia
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Russia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Netherlands
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Netherlands Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Sweden
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Sweden Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.2. Poland Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. AI-based Digital Pathology Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. South Korea
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. South Korea Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. Japan
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. Japan Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.11.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. AI-based Digital Pathology Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. AI-based Digital Pathology Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- AI-based Digital Pathology Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. DoMore Diagnostics AS
    • 12.2.2. Aiforia Technologies
    • 12.2.3. Aiosyn
    • 12.2.4. Deep Bio
    • 12.2.5. F. Hoffmann-La Roche
    • 12.2.6. Akoya Biosciences
    • 12.2.7. deepPath
    • 12.2.8. Hologic
    • 12.2.9. Konfoong Biotech International
    • 12.2.10. Koninklijke Philips N.V.
    • 12.2.11. 4D Path
    • 12.2.12. Lumea
    • 12.2.13. Ibex Medical Analytics
    • 12.2.14. Indica Labs
    • 12.2.15. Mindpeak
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제